These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12845301)

  • 1. Localized 1H-MR spectroscopy in moyamoya disease before and after revascularization surgery.
    Lim SM; Choi HY; Suh JS; Lee JH; Lim KH; Suh DC; Lee HK; Lim TH; Ra YS
    Korean J Radiol; 2003; 4(2):71-8. PubMed ID: 12845301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance spectroscopy in children with moyamoya disease.
    Shimizu H; Shirane R; Fujiwara S; Takahashi A; Yoshimoto T
    Clin Neurol Neurosurg; 1997 Oct; 99 Suppl 2():S64-7. PubMed ID: 9409409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
    Hayashi T; Shirane R; Fujimura M; Tominaga T
    J Neurosurg Pediatr; 2010 Jul; 6(1):73-81. PubMed ID: 20593991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of revascularization surgery evaluated by proton magnetic resonance spectroscopy and single photon emission computed tomography.
    Uno M; Ueda S; Hondo H; Matsumoto K; Harada M
    Neurol Med Chir (Tokyo); 1996 Aug; 36(8):560-6; discussion 566-7. PubMed ID: 8831198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
    Bladowska J; Zimny A; Kołtowska A; Szewczyk P; Knysz B; Gąsiorowski J; Furdal M; Sąsiadek MJ
    Eur J Radiol; 2013 Apr; 82(4):686-92. PubMed ID: 23246331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-course analysis of brain perfusion single photon emission computed tomography using a three-dimensional stereotactic region-of-interest template in patients with moyamoya disease.
    Marushima A; Tsurushima H; Suzuki K; Nakai Y; Nemoto H; Matsumura A
    World Neurosurg; 2011; 76(3-4):304-10. PubMed ID: 21986429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1H-magnetic resonance spectroscopy in a case of Moyamoya disease with revascularization surgery.
    Imamura A; Horikoshi H; Matsuo N; Okuda M; Tanigawara T; Enomoto Y; Yamakawa H; Hattori T
    Pediatr Int; 2006 Aug; 48(4):426-9. PubMed ID: 16911094
    [No Abstract]   [Full Text] [Related]  

  • 9. MR angiography of moyamoya disease before and after encephaloduroarteriosynangiosis.
    Yoon HK; Shin HJ; Lee M; Byun HS; Na DG; Han BK
    AJR Am J Roentgenol; 2000 Jan; 174(1):195-200. PubMed ID: 10628478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fire-related post-traumatic stress disorder: brain 1H-MR spectroscopic findings.
    Lim MK; Suh CH; Kim HJ; Kim ST; Lee JS; Kang MH; Kim JH; Lee JH
    Korean J Radiol; 2003; 4(2):79-84. PubMed ID: 12845302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton magnetic resonance spectroscopy: normal findings in the cerebellar hemisphere in childhood.
    Costa MO; Lacerda MT; Garcia Otaduy MC; Cerri GG; Da Costa Leite C
    Pediatr Radiol; 2002 Nov; 32(11):787-92. PubMed ID: 12389106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the late effects of CNS prophylactic treatment in childhood acute lymphoblastic leukemia (ALL) using magnetic resonance spectroscopy.
    Ficek K; Blamek S; Syguła D; Miszczyk L; Sońta-Jakimczyk D; Tarnawski R
    Acta Neurochir Suppl; 2010; 106():195-7. PubMed ID: 19812948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of occupational manganese exposure on the central nervous system of welders: 1H magnetic resonance spectroscopy and MRI findings.
    Kim EA; Cheong HK; Choi DS; Sakong J; Ryoo JW; Park I; Kang DM
    Neurotoxicology; 2007 Mar; 28(2):276-83. PubMed ID: 16824604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Brain metabolic disorders after chemotherapy in the study by magnetic resonance spectroscopy].
    Ciszkowska-Łysoń B; Królicki L; Teska A; Janowicz-Zebrowska A; Krzakowski M; Tacikowska M
    Neurol Neurochir Pol; 2003; 37(4):783-98. PubMed ID: 14746239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-field magnetic resonance imaging in patients with moyamoya disease.
    Harada A; Fujii Y; Yoneoka Y; Takeuchi S; Tanaka R; Nakada T
    J Neurosurg; 2001 Feb; 94(2):233-7. PubMed ID: 11213959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cerebral metabolic disturbance in hypoxic encephalopathy: evaluation with H-1 MR spectroscopy].
    Suzuki S; Ichijo M; Fujii H; Ikeda K; Hitosugi M
    Rinsho Shinkeigaku; 1996 Jul; 36(7):844-9. PubMed ID: 8952350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
    Sahin I; Alkan A; Keskin L; Cikim A; Karakas HM; Firat AK; Sigirci A
    J Diabetes Complications; 2008; 22(4):254-60. PubMed ID: 18413166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?
    Fayed N; Morales H; Modrego PJ; Muñoz-Mingarro J
    Acad Radiol; 2006 Feb; 13(2):229-35. PubMed ID: 16428059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
    Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.